ICD-9 2012 brings no urology-related revisions or deletions this time round.
The ICD-9 codes 2012 have just gone into effect on October 1 this year. Although your urology practice will not have to go through any ICD-9 revisions or deletions this time round, there are some new ICD-9 codes that you need to be well-versed with. Now you'll have more specific codes to use when a patient suffers from complications with a cystostomy or vaginal mesh.
ICD-9 changes for urology coders
Four new 596 codes: If you have been bogged down because you have to use non-specific inflammation and complication codes when a patient has a problem with cystostomy, there's a better choice in ICD-9 2012. Prior to this, coders in general have always had to use codes that were described as 'mechanical complications,' 'infection and inflammatory reaction,' or 'other complications.
Just-in way: You have these new codes now: 596.81, 596.82, and 596.83.
You will report 596.81 for a patient with an infection of the cystostomy stoma, inflammation of the stoma with or without an abscess formation, or for a granuloma within the stoma with or without an abscess formation or for a granuloma within the stoma. These scenarios represent inflammations or infections of the cystostomy for which you have a new code now.
You should use 596.82 when your urologist documents premature closure, stricture or stenosis of the cutaneous cystostomy stoma. These conditions represent mechanical complications of the cystostomy.
You should make use of just-in code 596.83 for complications such as persistent drainage, non-closure, prolapse of the mucosa, excoriation of the cystostomy site, bleeding, erosion, and the like. Often times after removal of a cystostomy tube, the site remains open with prolonged persistent drainage, non-closure, prolapse of the mucosa, excoriation of the cystostomy site, bleeding, erosion, and the like.
Two new codes to capture vaginal mesh complications
This time there are a couple of two new diagnoses related to implanted vaginal mesh in the ICD-9 2012 proposed codes: 629.31, 629.32.
Remember: There are no urology related revisions or deletions this time round.
Showing posts with label ICD-9 lookup. Show all posts
Showing posts with label ICD-9 lookup. Show all posts
Sunday, October 2, 2011
Wednesday, September 21, 2011
ICD-9 codes: Preop exams? Don't overlook V codes
Here's an ICD coding scenario that'll help you in your work when you start using 2012 ICD-9 codes from October 1, 2011.
ICD-9 2012 changes will go into effect in a week's time. So are you geared up to tackle a diagnostic test that comes back minus a definitive diagnosis? You'll overcome these challenges when you make it a point to convey to payers exactly what you found.
Scenario: A patient who is schedule to undergo a gall bladder surgery presents for a pre-op evaluation. The GI lists the condition talking about the surgery as acute cholecystitis (575.0) and the underlying medical condition as diabetes (250.xx).
How would you handle this situation? Should you report the screening code here?
Many a time, a physician would order a diagnostic test without any signs and symptoms or perform a preop evaluation for the patient. If the main reason for the encounter is preop evaluation, you should first list a code from category V72.8 (Other specified examinations) to describe the preop evaluation. After this, you need to report a code for the condition prompting the surgery as an additional diagnosis (here 575.0). If you find out any condition during the screening, it should be reported as additional diagnosis.
V codes take center stage too
When a patient has no signs or symptoms and the gastroenterologist carries out a test solely for screening purposes, V codes will take the limelight. In this situation, you should ignore typical diagnosis codes and locate an appropriate “V" code to describe the test to the payer.
Note of caution: You should tread carefully while using V codes because there are many payers out there who will not pay for claims with only a V code as a diagnosis, with the exception of physicals or covered preventative health services; even then they'll only shell out money for one adult physical each year.
Screening codes: If the reason for the visit is specifically the screening exam, you should list the screening code first. However, you need to report the screening code as an additional code if the physician carries out the screening during an office visit for other health woes. Moreover, if the screening returns an abnormal result, then you should code those results as an additional diagnosis.
ICD-9 2012 changes will go into effect in a week's time. So are you geared up to tackle a diagnostic test that comes back minus a definitive diagnosis? You'll overcome these challenges when you make it a point to convey to payers exactly what you found.
Scenario: A patient who is schedule to undergo a gall bladder surgery presents for a pre-op evaluation. The GI lists the condition talking about the surgery as acute cholecystitis (575.0) and the underlying medical condition as diabetes (250.xx).
How would you handle this situation? Should you report the screening code here?
Many a time, a physician would order a diagnostic test without any signs and symptoms or perform a preop evaluation for the patient. If the main reason for the encounter is preop evaluation, you should first list a code from category V72.8 (Other specified examinations) to describe the preop evaluation. After this, you need to report a code for the condition prompting the surgery as an additional diagnosis (here 575.0). If you find out any condition during the screening, it should be reported as additional diagnosis.
V codes take center stage too
When a patient has no signs or symptoms and the gastroenterologist carries out a test solely for screening purposes, V codes will take the limelight. In this situation, you should ignore typical diagnosis codes and locate an appropriate “V" code to describe the test to the payer.
Note of caution: You should tread carefully while using V codes because there are many payers out there who will not pay for claims with only a V code as a diagnosis, with the exception of physicals or covered preventative health services; even then they'll only shell out money for one adult physical each year.
Screening codes: If the reason for the visit is specifically the screening exam, you should list the screening code first. However, you need to report the screening code as an additional code if the physician carries out the screening during an office visit for other health woes. Moreover, if the screening returns an abnormal result, then you should code those results as an additional diagnosis.
Tuesday, August 30, 2011
ICD-9 Coding: Each Code in 173.X Series Will Get Fifth Digit Options
Although there are fewer changes to ICD-9 codes this year, oncology and hematology coders will have their hands full.
Here are the main proposals you need to keep an eye on when they go into effect on October 1, 2011. This time you can see an expansion of 173.x (Other malignant neoplasm of skin) as each code in that series will get fifth digit choices, which will provide further details of the skin neoplasm type.
The changes in skin cancer codes (173.xx) follow a pattern where the fifth digit of '0' refers to an unspecified malignant neoplasm, '1' denotes basal cell cancer (BCC), 2 refers to squamous cell carcinoma (SCC) while "9" describes "other" specified malignant neoplasm. The two most common types of skin cancer are basal cell cancer and specified malignant neoplasm.
Why the expansion? The code series was expanded following a request from the New York Cancer Registry to help distinguish reportable skin cancers from non-reportable skin cancers – say for instance BCC and SCC. These common neoplasms behave differently – so it would be more useful to separate them.
Right now, you use ICD code 173.0 for any non-melanoma malignant lip neoplasm; however using the proposed codes, you'll choose from: 173.00, 173.01, 173.02 and 173.09.
Four-digit 173.x codes will no longer be valid with effect from October 1, 2011
This is because each code in the range will need a fifth digit to be complete.
Better documentation habits: Preparing for the just-in and revised ICD-9 code changes, you need better documentation habits. You should encourage practitioners to document the type, specific location and nature of the disease process. You'll have a two-pronged advantage as improving documentation will not only allow you to code these conditions more specifically starting October this year but will also help you gear up for ICD-10's general increase in documentation requirements after it goes into effect on October 1, 2013.
What's more, you should also plan for ICD-9 2012 to expand the present four-digit code 286.5 into these five-digit codes: 286.52 (Acquired hemophilia ), 286.53 (Antiphospholipid antibody with hemorrhagic disorder), 286.59 (Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors).
The changes will help track trials on the cause, self-correction and pharmaceutical treatment of these disease types of hemophilia.
Here are the main proposals you need to keep an eye on when they go into effect on October 1, 2011. This time you can see an expansion of 173.x (Other malignant neoplasm of skin) as each code in that series will get fifth digit choices, which will provide further details of the skin neoplasm type.
The changes in skin cancer codes (173.xx) follow a pattern where the fifth digit of '0' refers to an unspecified malignant neoplasm, '1' denotes basal cell cancer (BCC), 2 refers to squamous cell carcinoma (SCC) while "9" describes "other" specified malignant neoplasm. The two most common types of skin cancer are basal cell cancer and specified malignant neoplasm.
Why the expansion? The code series was expanded following a request from the New York Cancer Registry to help distinguish reportable skin cancers from non-reportable skin cancers – say for instance BCC and SCC. These common neoplasms behave differently – so it would be more useful to separate them.
Right now, you use ICD code 173.0 for any non-melanoma malignant lip neoplasm; however using the proposed codes, you'll choose from: 173.00, 173.01, 173.02 and 173.09.
Four-digit 173.x codes will no longer be valid with effect from October 1, 2011
This is because each code in the range will need a fifth digit to be complete.
Better documentation habits: Preparing for the just-in and revised ICD-9 code changes, you need better documentation habits. You should encourage practitioners to document the type, specific location and nature of the disease process. You'll have a two-pronged advantage as improving documentation will not only allow you to code these conditions more specifically starting October this year but will also help you gear up for ICD-10's general increase in documentation requirements after it goes into effect on October 1, 2013.
What's more, you should also plan for ICD-9 2012 to expand the present four-digit code 286.5 into these five-digit codes: 286.52 (Acquired hemophilia ), 286.53 (Antiphospholipid antibody with hemorrhagic disorder), 286.59 (Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors).
The changes will help track trials on the cause, self-correction and pharmaceutical treatment of these disease types of hemophilia.
Friday, August 5, 2011
2012 ICD- 9-CM Codes: Get Four Options for Non-Melanoma Malignant Neoplasm of the Lip
Plus, new codes will make cancer classification easier.
The proposed changes to 2012 ICD-9 codes is out; approved by the ICD-9-CM Coordination and Maintenance Committee, the new, revised and invalid codes were published in the Federal Register on May 5, 2011. After the new codes go into effect on October 1 this year, CMS will add ICD-9 codes on an emergency basis as it gears up to switch over the diagnosis coding system to ICD-10.
Expanded ICD-9 diagnosis code sets: As per the changes, from October 1 this year, dermatology coders will be able to report the location of carcinomas and other neoplasms of the skin more accurately. This time they include an expansion of the 173.x (Other malignant neoplasm of skin) series. Each code in that series will get a list of fifth digits that'll provide specifications on whether the malignant neoplasm is basal cell, squamous cell, or unspecified.
Source Code :- http://www.supercoder.com/icd9-codes/
ICD 9 codes 2011: Right now dermatology coders use 173.0 for any non-melanoma malignant neoplasm of the lip. This will become an invalid code once ICD-9 2012 codes go into effect.
ICD-9 codes 2012: When the ICD-9 2012 goes into effect, coders can choose from four options - 173.00, 173.01, 173.02 and 173.09.
New codes will make cancer classification easier: Normally, majority of skin cancers are either basal or squamous cell, neither of which are reportable conditions to central cancer registries. Due to the difficulty in distinguishing reportable skin cancers from non-reportable skin cancers, the facilities are transmitting skin cancers to central registries. This puts an additional burden on central registries and also ends up in the transmission of confidential patient information on patients whose information shouldn't be reported. The expansion of the category of 173 codes will allow for the differentiation of reportable and non-reportable skin cancer.
ICD-10 codes: We're not sure whether there'll be expanded skin neoplasm codes when coders update their diagnosis codes in 2013 with the new code set. Presently, ICD-10 is likely to include C44.0-C44.9, a code series that does not have the specificity as the soon-to-go-into-effect ICD-9 2012 codes.
The proposed changes to 2012 ICD-9 codes is out; approved by the ICD-9-CM Coordination and Maintenance Committee, the new, revised and invalid codes were published in the Federal Register on May 5, 2011. After the new codes go into effect on October 1 this year, CMS will add ICD-9 codes on an emergency basis as it gears up to switch over the diagnosis coding system to ICD-10.
Expanded ICD-9 diagnosis code sets: As per the changes, from October 1 this year, dermatology coders will be able to report the location of carcinomas and other neoplasms of the skin more accurately. This time they include an expansion of the 173.x (Other malignant neoplasm of skin) series. Each code in that series will get a list of fifth digits that'll provide specifications on whether the malignant neoplasm is basal cell, squamous cell, or unspecified.
Source Code :- http://www.supercoder.com/icd9-codes/
ICD 9 codes 2011: Right now dermatology coders use 173.0 for any non-melanoma malignant neoplasm of the lip. This will become an invalid code once ICD-9 2012 codes go into effect.
ICD-9 codes 2012: When the ICD-9 2012 goes into effect, coders can choose from four options - 173.00, 173.01, 173.02 and 173.09.
New codes will make cancer classification easier: Normally, majority of skin cancers are either basal or squamous cell, neither of which are reportable conditions to central cancer registries. Due to the difficulty in distinguishing reportable skin cancers from non-reportable skin cancers, the facilities are transmitting skin cancers to central registries. This puts an additional burden on central registries and also ends up in the transmission of confidential patient information on patients whose information shouldn't be reported. The expansion of the category of 173 codes will allow for the differentiation of reportable and non-reportable skin cancer.
ICD-10 codes: We're not sure whether there'll be expanded skin neoplasm codes when coders update their diagnosis codes in 2013 with the new code set. Presently, ICD-10 is likely to include C44.0-C44.9, a code series that does not have the specificity as the soon-to-go-into-effect ICD-9 2012 codes.
Subscribe to:
Posts (Atom)